Securities code: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) securities abbreviation: Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) Announcement No.: 2022022
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864)
Announcement of resolutions of the 18th meeting of the third board of supervisors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Meetings of the board of supervisors
1. Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) (hereinafter referred to as “the company”) the notice of the 18th meeting of the third board of supervisors was sent to all supervisors by email on March 28, 2022.
2. The meeting was held at 10:30 a.m. on March 31, 2022 in the conference room on the second floor of Shaanxi Panlong Pharmaceutical Co., Ltd., No. 2801, Baliu Second Road, modern textile industrial park, Baqiao District, Xi’an. The meeting was conducted by combining on-site and communication.
3. There are 5 supervisors who should attend and 5 supervisors who actually attend. Among them, Jian Baoliang, the employee representative supervisor, participated in the voting by means of communication.
4. Mr. Luo Qingshui, chairman of the board of supervisors of the company, presided over the meeting.
5. The notice, convening and convening of this meeting comply with the company law of the people’s Republic of China and other laws, administrative regulations, departmental rules, normative documents and the relevant provisions of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) articles of association.
2、 Deliberation at the meeting of the board of supervisors
(I) deliberated and passed the proposal on the company’s use of idle raised funds for cash management
For details, please refer to China Securities News, Shanghai Securities News, securities times, securities daily and cninfo.com published on the same day（ http://www.cn.info.com.cn. ）The announcement of Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) on the company’s use of idle raised funds for cash management (Announcement No.: 2022023) disclosed.
After review, the board of supervisors believes that the company’s use of idle raised funds for cash management and purchase of financial products can improve the use efficiency and income of idle raised funds, will not affect the normal development and normal production and operation of the company’s investment projects with raised funds, and there is no damage to the interests of the company and minority shareholders. The decision-making and deliberation procedures of this matter are legal and compliant, The company agrees to use idle raised funds to purchase low-risk financial products with high safety and good liquidity issued by the bank.
Voting results: 5 affirmative votes, 0 negative votes and 0 abstention votes.
(II) deliberated and passed the proposal on applying for 100 million yuan short-term working capital loan from Bank Of China Limited(601988) Xi’an high tech Development Zone sub branch and providing guarantee to the actual controller of the company
Proposal content: for the further development of the company, the company plans to apply to Bank Of China Limited(601988) Xi’an high tech Development Zone sub branch for a loan of 100 million yuan for daily operation, with a loan term of one year, and the actual controller Xie Xiaolin and his spouse provide joint and several liability guarantee.
There were no affirmative votes and 5 abstentions.
3、 Documents for future reference
1. Resolutions of the 18th meeting of the third board of supervisors of the company;
2. Other documents required by SZSE.
Shanxi Panlong Pharmaceutical Group Limited By Share Ltd(002864) board of supervisors April 1, 2022
